Answers are grounded in this paper and cite their sources.
Hepatitis C (HCV) is the most common blood-borne infection in the US and affects the majority of long-term injection drug users. Despite this, little is known about the natural history and treatment of HCV in this population. This article provides an overview of HCV epidemiology and natural history as it relates to injection drug users, and describes the basis of diagnostic testing and HCV treatment for the addiction provider. It further reviews the data on HCV treatment barriers in IDUs as a means of understanding and assessing HCV treatment candidacy.
No takes yet. Share an insight, caveat, or question.
Diana L. Sylvestre (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: